These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20596252)

  • 1. T-cell infiltration in autosomal dominant neovascular inflammatory vitreoretinopathy.
    Mahajan VB; Vallone JG; Lin JH; Mullins RF; Ko AC; Folk JC; Stone EM
    Mol Vis; 2010 Jun; 16():1034-40. PubMed ID: 20596252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte infiltration in CAPN5 autosomal dominant neovascular inflammatory vitreoretinopathy.
    Mahajan VB; Lin JH
    Clin Ophthalmol; 2013; 7():1339-45. PubMed ID: 23861576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic linkage of autosomal dominant neovascular inflammatory vitreoretinopathy to chromosome 11q13.
    Stone EM; Kimura AE; Folk JC; Bennett SR; Nichols BE; Streb LM; Sheffield VC
    Hum Mol Genet; 1992 Dec; 1(9):685-9. PubMed ID: 1284594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of neovascularization but not fibrosis with the fluocinolone acetonide implant in autosomal dominant neovascular inflammatory vitreoretinopathy.
    Tlucek PS; Folk JC; Orien JA; Stone EM; Mahajan VB
    Arch Ophthalmol; 2012 Nov; 130(11):1395-401. PubMed ID: 22777573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monozygotic twins with CAPN5 autosomal dominant neovascular inflammatory vitreoretinopathy.
    Rowell HA; Bassuk AG; Mahajan VB
    Clin Ophthalmol; 2012; 6():2037-44. PubMed ID: 23271883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferative vitreoretinopathy. Lymphocytes in epiretinal membranes.
    Charteris DG; Hiscott P; Grierson I; Lightman SL
    Ophthalmology; 1992 Sep; 99(9):1364-7. PubMed ID: 1407970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory cells in proliferative vitreoretinopathy subretinal membranes.
    Charteris DG; Hiscott P; Robey HL; Gregor ZJ; Lightman SL; Grierson I
    Ophthalmology; 1993 Jan; 100(1):43-6. PubMed ID: 8094546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Outcomes and Risk Factors for Severe Vision Loss in Autosomal Dominant Neovascular Inflammatory Vitreoretinopathy (ADNIV).
    Boyce TM; Whitmore SS; Varzavand K; Russell SR; Sohn EH; Folk JC; Stone EM; Han IC
    Am J Ophthalmol; 2022 Jan; 233():144-152. PubMed ID: 34302771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistologic study of epiretinal membranes in proliferative vitreoretinopathy.
    Baudouin C; Fredj-Reygrobellet D; Gordon WC; Baudouin F; Peyman G; Lapalus P; Gastaud P; Bazan NG
    Am J Ophthalmol; 1990 Dec; 110(6):593-8. PubMed ID: 1701071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional validation of a human CAPN5 exome variant by lentiviral transduction into mouse retina.
    Wert KJ; Skeie JM; Bassuk AG; Olivier AK; Tsang SH; Mahajan VB
    Hum Mol Genet; 2014 May; 23(10):2665-77. PubMed ID: 24381307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical management of fibrotic encapsulation of the fluocinolone acetonide implant in CAPN5-associated proliferative vitreoretinopathy.
    Tlucek PS; Folk JC; Sobol WM; Mahajan VB
    Clin Ophthalmol; 2013; 7():1093-8. PubMed ID: 23785231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multilaminated Vitreomacular Traction in Autosomal Dominant Neovascular Inflammatory Vitreoretinopathy.
    Han IC; Critser DB; Folk JC
    Ophthalmol Retina; 2019 Jul; 3(7):588. PubMed ID: 31277800
    [No Abstract]   [Full Text] [Related]  

  • 13. The histopathology of familial exudative vitreoretinopathy. A report of two cases.
    Boldrey EE; Egbert P; Gass JD; Friberg T
    Arch Ophthalmol; 1985 Feb; 103(2):238-41. PubMed ID: 3977696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital retinal fold as a sign of dominant exudative vitreoretinopathy.
    van Nouhuys CE
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1981; 217(1):55-67. PubMed ID: 6911005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocytes, macrophages and HLA-DR expression in vitreal and epiretinal membranes of proliferative vitreoretinopathy. An immunohistochemical study.
    Tang S; Scheiffarth OF; Wildner G; Thurau SR; Lund OE
    Ger J Ophthalmol; 1992; 1(3-4):176-9. PubMed ID: 1483132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early-onset Neovascular Inflammatory Vitreoretinopathy Due to Two de Novo CAPN5 Mutations in Chinese Patients: A Case Series.
    Xia FJ; Lyu J; Zhang X; Fei P; Zhao PQ
    Ocul Immunol Inflamm; 2023 Nov; 31(9):1777-1784. PubMed ID: 36369866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response to specific molecules of the retina in proliferative vitreoretinal disorders.
    Grisanti S; Heimann K; Wiedemann P
    Graefes Arch Clin Exp Ophthalmol; 1994 May; 232(5):302-7. PubMed ID: 8045440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Criswick-Schepens syndrome (familial exudative vitreoretinopathy). Study of a Colombian kindred.
    Nicholson DH; Galvis V
    Arch Ophthalmol; 1984 Oct; 102(10):1519-22. PubMed ID: 6487118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary glaucoma in CAPN5-associated neovascular inflammatory vitreoretinopathy.
    Cham A; Bansal M; Banda HK; Kwon Y; Tlucek PS; Bassuk AG; Tsang SH; Sobol WM; Folk JC; Yeh S; Mahajan VB
    Clin Ophthalmol; 2016; 10():1187-97. PubMed ID: 27390515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CAPN5 mutation in hereditary uveitis: the R243L mutation increases calpain catalytic activity and triggers intraocular inflammation in a mouse model.
    Wert KJ; Bassuk AG; Wu WH; Gakhar L; Coglan D; Mahajan M; Wu S; Yang J; Lin CS; Tsang SH; Mahajan VB
    Hum Mol Genet; 2015 Aug; 24(16):4584-98. PubMed ID: 25994508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.